Literature DB >> 7720042

Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer.

C Dickson1, V Fantl, C Gillett, S Brookes, J Bartek, R Smith, C Fisher, D Barnes, G Peters.   

Abstract

In this paper we describe how research on the mouse mammary tumor virus model of breast cancer resulted in the identification of an amplified region of DNA on human chromosome 11 band q13. This amplification occurs in approximately 15% of primary breast cancers. Several candidate oncogenes map within the amplicon but by analysing expression of these genes a strong case can be made for a role for cyclin D1 in tumorigenesis. Immunohistochemical staining indicates that cyclin D1 is expressed at elevated levels in around 40% of breast cancers, including those with the 11q13 amplification. The potential function of cyclin D1 as a regulator of early cell division cycle events would be consistent with a role in neoplasia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7720042     DOI: 10.1016/0304-3835(94)03676-a

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  57 in total

Review 1.  A specific role for cyclin D1 in mammary gland development.

Authors:  P Sicinski; R A Weinberg
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-10       Impact factor: 2.673

2.  Down-regulation of cyclin D1 expression by prostaglandin A(2) is mediated by enhanced cyclin D1 mRNA turnover.

Authors:  S Lin; W Wang; G M Wilson; X Yang; G Brewer; N J Holbrook; M Gorospe
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

3.  MUC1-C oncoprotein induces TCF7L2 transcription factor activation and promotes cyclin D1 expression in human breast cancer cells.

Authors:  Hasan Rajabi; Rehan Ahmad; Caining Jin; Michio Kosugi; Maroof Alam; Maya Datt Joshi; Donald Kufe
Journal:  J Biol Chem       Date:  2012-02-08       Impact factor: 5.157

4.  Assessment of palindromes as platforms for DNA amplification in breast cancer.

Authors:  Jamie Guenthoer; Scott J Diede; Hisashi Tanaka; Xiaoyu Chai; Li Hsu; Stephen J Tapscott; Peggy L Porter
Journal:  Genome Res       Date:  2011-07-13       Impact factor: 9.043

Review 5.  The role of the RB tumour suppressor pathway in oxidative stress responses in the haematopoietic system.

Authors:  Kay F Macleod
Journal:  Nat Rev Cancer       Date:  2008-09-18       Impact factor: 60.716

6.  THRSP (thyroid hormone responsive).

Authors:  Nancy B Kuemmerle; William B Kinlaw
Journal:  Atlas Genet Cytogenet Oncol Haematol       Date:  2011-06

Review 7.  Role of the androgen receptor in triple-negative breast cancer.

Authors:  Murtuza Rampurwala; Kari B Wisinski; Ruth O'Regan
Journal:  Clin Adv Hematol Oncol       Date:  2016-03

8.  High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells.

Authors:  Xin Huang; Susanne M Gollin; Siva Raja; Tony E Godfrey
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-09       Impact factor: 11.205

9.  FISH is more sensitive than Southern analysis at identifying increased levels of cyclin D1 gene amplified in breast cancer cell lines.

Authors:  Nie Dongsong; Jian Y Zhou
Journal:  Mol Biol Rep       Date:  2009-12-05       Impact factor: 2.316

10.  PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro.

Authors:  Richard S Finn; Judy Dering; Dylan Conklin; Ondrej Kalous; David J Cohen; Amrita J Desai; Charles Ginther; Mohammad Atefi; Isan Chen; Camilla Fowst; Gerret Los; Dennis J Slamon
Journal:  Breast Cancer Res       Date:  2009       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.